2026 Die neuesten ExamFragen ACNS PDF-Versionen Prüfungsfragen und ACNS Fragen und Antworten sind kostenlos verfügbar: https://drive.google.com/open?id=1t02JktObaHz_-wKGGqYZYxnlCcvGqau7
Wenn wir am Anfang die Fragenkataloge zur Nursing ACNS Zertifizierungsprüfung bieteten, haben wir niemals geträumt, dass wir so einen guten Ruf bekommen können. Wir geben Ihnen die unglaubliche Garantie. Wenn Sie die Produkte von ExamFragen für Ihre Nursing ACNS Zertifizierungsprüfung benutzen, versprechen wir Ihnen, die Prüfung 100% zu bestehen.
| Section | Weight | Objectives |
|---|---|---|
| Topic 1: Health Care Systems and Policy | 5% | - Regulatory and Policy Frameworks - Resource Management - Healthcare Delivery Models |
| Topic 2: Role and Professional Responsibility | 33% | - Evidence-Based Practice and Research - Clinical Leadership and Consultation - Quality Improvement and Safety - Ethics and Legal Aspects - Education and Mentorship |
| Topic 3: Clinical Practice | 46% | - Health Promotion and Disease Prevention - Health Assessment and Diagnosis - Care Planning and Implementation - Pharmacologic and Nonpharmacologic Management - Evaluation of Outcomes |
| Topic 4: APRN Core Competencies | 16% | - Advanced Pharmacology - Advanced Health Assessment - Advanced Pathophysiology |
Geben Sie sich alle erdenkliche Mühe, um die richtige Prüfungsmaterialien für die Nursing ACNS Zertifizierungsprüfung in dieser komplizierten und wechselhaften Informationsepoche zu finden? Wir freuen uns darüber, dass Sie ExamFragen, dieser echte und zuversichtliche Ausbildungsmaterialien zur Nursing ACNS Zertifizierungsprüfung schließlich finden. Sie werden Ihnen helfen, das schätzige Nursing ACNS Prüfungszertifikat von zu erhalten.
61. Frage
A 38 year obese female patient has Type II diabetes and Stage I hypertension. What is the recommended goal for her LDL level?
Antwort: B
Begründung:
The question pertains to the appropriate goal for low-density lipoprotein (LDL) cholesterol in a 38-year-old obese female with Type II diabetes and Stage I hypertension. Managing LDL cholesterol is crucial in patients with multiple cardiovascular risk factors to prevent complications such as heart disease and stroke.
Patients with diabetes are at a higher risk of cardiovascular diseases, akin to the risk faced by individuals who have already experienced a heart attack. This elevated risk is further compounded by other factors such as obesity and hypertension. Thus, more aggressive management of lipid levels, particularly LDL cholesterol, is warranted.
According to current guidelines, for individuals with diabetes and additional cardiovascular risk factors, the recommended LDL cholesterol level should be less than 100 mg/dL. This target is set to minimize the risk of atherosclerotic events, which can lead to severe cardiovascular complications. Achieving lower LDL levels is associated with a significant reduction in the risk of heart attacks, strokes, and coronary artery disease.
Therefore, for a patient like the one described, who not only has diabetes but is also hypertensive and obese, maintaining an LDL cholesterol level below 100 mg/dL is crucial. This goal is part of a broader strategy aimed at comprehensive cardiovascular risk reduction, which includes managing blood sugar levels, blood pressure, and body weight, alongside improving lipid profiles.
In conclusion, the correct answer to the question of the recommended LDL level for this patient is <100 mg/dL. This target is consistent with the guidelines aiming to provide maximum protection against cardiovascular diseases in high-risk individuals such as those with diabetes and hypertension.
62. Frage
Lead screening during well-child examinations and cholesterol screening for adults are both examples of what type of prevention?
Antwort: C
Begründung:
The correct answer to the question regarding the type of prevention exemplified by lead screening during well-child examinations and cholesterol screening for adults is "secondary prevention." This category of prevention is crucial in the healthcare field as it focuses on the early detection and timely intervention of diseases, which can prevent the progression of a condition and mitigate adverse outcomes.
Secondary prevention operates during the subclinical stage of a disease, which means that the disease is present but not yet symptomatic or fully developed. This stage provides a critical opportunity for healthcare professionals to intervene and prevent the disease from advancing. For example, lead screening in children is intended to catch lead poisoning before it causes significant health issues like developmental delays or learning disabilities. Similarly, cholesterol screening in adults aims to identify elevated cholesterol levels early, which can lead to preventive measures against cardiovascular diseases such as heart attacks or strokes.
The goal of secondary prevention is not just to detect the disease early, but also to implement measures that can reduce its impact or severity. This might include medication, lifestyle changes, or more frequent monitoring. By catching problems at a stage when they are more manageable, secondary prevention can significantly improve patient outcomes and reduce the need for more intensive treatments that might be required at later stages.
In contrast, primary prevention involves strategies to prevent the onset of disease before it occurs. This can include vaccinations, enforcing safe work practices, or promoting healthy diets and exercise. Tertiary prevention, on the other hand, deals with reducing the impact of ongoing illness that has lasting effects, such as rehabilitation for stroke patients and ongoing management and care for chronic diseases. Quaternary prevention aims to prevent overmedicalization and the negative effects of unnecessary health interventions.
Understanding these distinctions is crucial for effective health management and policy-making. Each level of prevention plays a unique role in the healthcare system, contributing to the overall health and well-being of the population. Secondary prevention, as demonstrated by lead and cholesterol screenings, serves as a bridge between the proactive measures of primary prevention and the responsive strategies of tertiary care, optimizing health outcomes by addressing diseases early in their development.
63. Frage
A patient following a renal diet for kidney disease should limit his phosphorus intake to which of the following?
Antwort: A
Begründung:
When managing kidney disease, dietary adjustments are crucial due to the kidneys' impaired ability to filter and eliminate certain substances efficiently. Phosphorus, a common dietary mineral found in many foods, is one of the substances that individuals with kidney disease need to regulate. Excessive phosphorus in the bloodstream can lead to serious health complications, including bone disease and calcification of tissues.
For patients with kidney disease following a renal diet, it's generally advised to limit phosphorus intake to about 1000 mg per day. This recommendation can vary based on the stage of kidney disease and the specific health needs of the individual, so it's important for patients to work closely with a healthcare provider or dietitian to tailor dietary intake appropriately.
Phosphorus is present in high amounts in foods like dairy products, nuts, seeds, beans, and whole grains, as well as in processed foods and soft drinks in the form of additives. Due to its prevalence in many types of foods, managing phosphorus intake requires careful dietary planning.
The limitation of 1000 mg per day helps to prevent the accumulation of phosphorus in the blood, which can help protect the bones and cardiovascular system. Keeping phosphorus levels controlled also helps to maintain a healthier balance with calcium and other minerals that are critical for bone health and overall physiological functions.
In summary, for a patient following a renal diet for kidney disease, limiting phosphorus intake to 1000 mg per day is essential. This approach not only supports kidney function but also contributes to a better quality of life by preventing complications associated with excessive phosphorus levels in the body. Regular consultations with healthcare providers are necessary to adjust the diet as the condition progresses or as the patient's needs change.
64. Frage
What is the BRANCH of philosophy that deals with the nature and justification of the principles guiding conduct?
Antwort: C
Begründung:
Ethics is the branch of philosophy that specifically focuses on the principles that govern right and wrong behavior, often referred to as moral philosophy. This field addresses questions about morality and evaluates the nature of values and the standards by which human actions can be judged right or wrong. The study of ethics involves various ethical theories that provide frameworks within which moral issues can be analyzed and resolved.
Ethics delves into the reasoning behind moral judgments and the justification of these judgments. It seeks to understand the underlying basis of moral principles and how they should be applied in real-world situations. This examination includes exploring the sources of ethical principles, whether they stem from cultural practices, logical reasoning, religious beliefs, or personal intuition.
Within the broader field of ethics, there are several sub-disciplines that focus on specific areas of ethical inquiry. For example, bioethics deals with ethical questions surrounding medical and biological research. It addresses issues such as the rights of patients and subjects, the implications of genetic engineering, and the allocation of scarce healthcare resources. Other sub-fields include business ethics, which looks at moral dilemmas in commerce and industry, and environmental ethics, which considers the ethical aspects of environmental conservation and sustainability.
By studying ethics, individuals and societies can better navigate complex moral dilemmas and work towards more ethical outcomes in various aspects of human life. The principles and theories explored in ethics not only guide personal behavior but also influence laws, policies, and global standards. Thus, ethics is a crucial field of philosophy that supports the foundation of a just and moral society.
65. Frage
Of the following which is a promotility agent you'd prescribe for your patient's gastrointestinal disorder?
Antwort: B
Begründung:
To answer the question about which drug is a promotility agent that could be prescribed for a patient's gastrointestinal disorder, it is essential to understand what each listed medication is typically used for and how they function.
**Metoclopramide:** This is the correct answer to the question. Metoclopramide is a well-known promotility agent used primarily to treat nausea, vomiting, and gastroparesis (delayed gastric emptying). It works by enhancing the motility of the stomach and intestines, which helps speed the movement of food through the gastrointestinal tract. It acts by blocking dopamine receptors and increasing the release of acetylcholine in the gut, which stimulates gastric motility and accelerates gastric emptying. It's often prescribed under the brand name Reglan.
**Senna:** This is not a promotility agent but rather a stimulant laxative. Senna works by irritating the lining of the bowel, which causes a laxative effect. It is primarily used to treat constipation and to clear the bowel before diagnostic tests such as colonoscopy. Senna does not enhance the motility of the upper gastrointestinal tract and thus is not useful as a promotility agent.
**Tegaserod:** This medication is a selective 5-HT4 receptor agonist that was used to treat irritable bowel syndrome (IBS) with constipation and chronic idiopathic constipation. It works by mimicking the action of serotonin at the 5-HT4 receptor, enhancing peristaltic reflex and intestinal secretion, which helps increase gastrointestinal motility. However, it is not typically classified as a promotility agent like Metoclopramide, and its use has been limited due to concerns over cardiovascular side effects.
**Alosetron:** This drug is a selective 5-HT3 receptor antagonist used primarily for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in women. Alosetron works by blocking serotonin receptors in the gastrointestinal tract, reducing bowel motility, and enhancing absorption. It effectively manages symptoms of IBS but does not promote motility; rather, it slows it down in cases of diarrhea-predominant IBS.
In conclusion, among the options provided, Metoclopramide is the only appropriate promotility agent for treating gastrointestinal disorders that involve delayed gastric emptying or reduced motility. The other listed drugs serve different purposes and act through mechanisms that do not enhance gastrointestinal motility in the way promotility agents like Metoclopramide do.
66. Frage
......
ExamFragen ist eine Website, die alle Informationen zur verschiedenen Nursing -Zertifizierungsprüfungen bieten kann. ExamFragen kann die besten und neuesten Prüfungsressourcen für Sie bereitstellen. Wenn Sie ExamFragen wählen, können Sie sich unbesorgt auf Ihre Nursing ACNS Zertifizierungsprüfung vorbereiten. Unsere Prüfungsunterlagen garantieren Ihnen, dass Sie 100% die Nursing ACNS Zertifizierungsprüfung bestehen können. Wenn nicht, geben wir Ihnen eine volle Rückerstattung oder akutualisieren schnell die Nursing ACNS Prüfungsfragen- und antworten. ExamFragen kann Ihnen Hilfe bei der Nursing ACNS Zertifizierungsprüfung sowie bei Ihrer zukünftigen Arbeit bieten. Zwar gibt es viele Möglichkeiten, die Ihnen zu Ihrem Ziel verhelfen, aber es ist die klügste Wahl, wenn Sie ExamFragen wählen. Mit ExamFragen können Sie mit wenigem Geld die Prüfung sicherer bestehen. Außerdem bieten wir Ihnen einjährigen kostenlosen Update-Service.
ACNS Prüfungsfrage: https://www.examfragen.de/ACNS-pruefung-fragen.html
P.S. Kostenlose 2026 Nursing ACNS Prüfungsfragen sind auf Google Drive freigegeben von ExamFragen verfügbar: https://drive.google.com/open?id=1t02JktObaHz_-wKGGqYZYxnlCcvGqau7